TY - JOUR
T1 - Determination of the Plasmodium vivax schizont stage proteome
AU - Roobsoong, Wanlapa
AU - Roytrakul, Sittiruk
AU - Sattabongkot, Jetsumon
AU - Li, Jianyong
AU - Udomsangpetch, Rachanee
AU - Cui, Liwang
N1 - Funding Information:
This work was supported by grant R21AI069126 from NIAID , D43-TW006571 from the Fogarty International Center, NIH and the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative. WR was a fellow supported by the Fogarty International Center, NIH ( D43-TW006571 ) and by the Royal Golden Jubilee Ph.D. Program ( 5TMU47H2 ). We would like to thank the staff at Biotech, Thailand Science Park, and laboratory members at the Department of Entomology and the core facilities of the Hershey Medical Center, Penn State University for technical assistance.
PY - 2011/8/24
Y1 - 2011/8/24
N2 - With the genome of the malaria parasite Plasmodium vivax sequenced, it is important to determine the proteomes of the parasite in order to assist efforts in antigen and drug target discovery. Since a method for continuous culture of P. vivax parasite is not available, we tried to study the proteome of the erythrocytic stages using fresh parasite isolates from patients. In schizont-enriched samples, 316 proteins were confidently identified by tandem mass spectrometry. Almost 50% of the identified proteins were hypothetical, while other major categories include proteins with binding function, protein fate, protein synthesis, metabolism and cellular transport. To identify proteins that are recognized by host humoral immunity, parasite proteins were separated by two-dimensional gel electrophoresis and screened by Western blot using an immune serum from a P. vivax patient. Mass spectrometry analysis of protein spots recognized by the serum identified four potential antigens including PV24. The recombinant protein PV24 was recognized by antibodies from vivax malaria patients even during the convalescent period, indicating that PV24 could elicit long-lasting antibody responses in P. vivax patients.
AB - With the genome of the malaria parasite Plasmodium vivax sequenced, it is important to determine the proteomes of the parasite in order to assist efforts in antigen and drug target discovery. Since a method for continuous culture of P. vivax parasite is not available, we tried to study the proteome of the erythrocytic stages using fresh parasite isolates from patients. In schizont-enriched samples, 316 proteins were confidently identified by tandem mass spectrometry. Almost 50% of the identified proteins were hypothetical, while other major categories include proteins with binding function, protein fate, protein synthesis, metabolism and cellular transport. To identify proteins that are recognized by host humoral immunity, parasite proteins were separated by two-dimensional gel electrophoresis and screened by Western blot using an immune serum from a P. vivax patient. Mass spectrometry analysis of protein spots recognized by the serum identified four potential antigens including PV24. The recombinant protein PV24 was recognized by antibodies from vivax malaria patients even during the convalescent period, indicating that PV24 could elicit long-lasting antibody responses in P. vivax patients.
UR - http://www.scopus.com/inward/record.url?scp=80051671243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80051671243&partnerID=8YFLogxK
U2 - 10.1016/j.jprot.2011.03.035
DO - 10.1016/j.jprot.2011.03.035
M3 - Article
C2 - 21515433
AN - SCOPUS:80051671243
SN - 1874-3919
VL - 74
SP - 1701
EP - 1710
JO - Journal of Proteomics
JF - Journal of Proteomics
IS - 9
ER -